{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:03Z","timestamp":1792089963039,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011928","name":"Ovarian Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>A nationwide nurse-led telehealth case management program was established providing personalised supportive care to individuals and families experiencing ovarian cancer. The program was evaluated using the RE-AIM framework. This paper focuses on the effectiveness findings of the evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using mixed methods design, participants completed four surveys over 12\u00a0months assessing symptom burden, psychological distress, supportive care needs, quality of life, and self-efficacy. Service experiences were further explored through interviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 652 individuals enrolled in the program, 112 (17%) participated in the evaluation. Predominant baseline moderate to severe symptoms were fatigue (65%); anxiety (56%); and sleep issues (50%). Key unmet needs included: uncertainty about the future (54%); fear of cancer spread (48%); and anxiety (42%). 43% reported high distress; 27% lacked confidence self-managing fatigue, 23% self-managing distress. All participants received symptom and needs assessment; 80% received information support, and one-third accessed specialised psychosocial care. Those with greater symptom burden, distress, lower quality of life and self-efficacy at baseline received more services. Over 12\u00a0months, overall wellbeing and satisfaction with information improved significantly. 30 interview participants consistently valued the program for: being seen and heard as a whole person; trusted information and advice; meaningful emotional support; and flexible and timely services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Participation in this nurse-led telehealth program was associated with improved outcomes and positive experiences among individuals with ovarian cancer who are at high risk of poorer outcomes. These findings support continued investment in person-centred tailored supportive care delivered via telehealth prioritising emotional wellbeing, symptom management, and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11284-8","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:44Z","timestamp":1791328904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimising ovarian cancer care: An embedded mixed methods evaluation of a national nurse-led telehealth program"],"prefix":"10.1007","volume":"34","author":[{"given":"Patsy","family":"Yates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanissa","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Hegarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Bradhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"11284_CR1","unstructured":"Australian Institute of Health and Welfare (2024). Cancer data in Australia. Canberra: Australian Institute of Health and Welfare. Available from: https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia. Accessed 30 June 2025."},{"key":"11284_CR2","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","volume":"374","author":"BT Hennessy","year":"2009","unstructured":"Hennessy BT, Coleman RL, Markman M (2009) Ovarian cancer. Lancet 374:1371\u20131382","journal-title":"Lancet"},{"key":"11284_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM (2019) Epithelial ovarian cancer. Lancet 393:1240\u20131253","journal-title":"Lancet"},{"issue":"12","key":"11284_CR4","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/ijgc-2020-002001","volume":"30","author":"CA Logue","year":"2020","unstructured":"Logue CA, Pugh J, Jayson G (2020) Psychosexual morbidity in women with ovarian cancer. Int J Gynecol Cancer 30(12):1983\u20131989","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"11284_CR5","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1017\/S1478951515000127","volume":"13","author":"M Ozga","year":"2015","unstructured":"Ozga M, Aghajanian C, Myers-Virtue S et al (2015) A systematic review of ovarian cancer and fear of recurrence. Palliat Support Care 13(6):1771\u20131780","journal-title":"Palliat Support Care"},{"key":"11284_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007618","volume":"5","author":"S Watts","year":"2015","unstructured":"Watts S, Prescott P, Mason J et al (2015) Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 5:e007618","journal-title":"BMJ Open"},{"key":"11284_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11764-016-0525-8","volume":"10","author":"D Ahmed-Lecheheb","year":"2016","unstructured":"Ahmed-Lecheheb D, Joly F (2016) Ovarian cancer survivors\u2019 quality of life: a systematic review. J Cancer Surviv 10:789\u2013801","journal-title":"J Cancer Surviv"},{"issue":"6","key":"11284_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/ijgc-2021-003142","volume":"32","author":"YC Lee","year":"2022","unstructured":"Lee YC, King MT, O\u2019Connell RL et al (2022) Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study. Int J Gynecol Cancer 32(6):761\u2013768","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"11284_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ygyno.2019.08.009","volume":"155","author":"K Webber","year":"2019","unstructured":"Webber K, Carolus E, Mileshkin L et al (2019) OVQUEST \u2013 life after the diagnosis and treatment of ovarian cancer - an international survey of symptoms and concerns in ovarian cancer survivors. Gynecol Oncol 155(1):126\u2013134","journal-title":"Gynecol Oncol"},{"issue":"2","key":"11284_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ygyno.2021.12.006","volume":"164","author":"VL Beesley","year":"2022","unstructured":"Beesley VL, Ross TL, King MT et al (2022) Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (measure of ovarian symptoms and treatment concerns). Gynecol Oncol 164(2):437\u2013445","journal-title":"Gynecol Oncol"},{"issue":"10","key":"11284_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejon.2017.07.007","volume":"30","author":"J-H Nho","year":"2017","unstructured":"Nho J-H, Kim SR, Nam J-H (2017) Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy. Eur J Oncol Nurs 30(10):8\u201314","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"11284_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00520-022-07501-9","volume":"31","author":"M Krishnasamy","year":"2023","unstructured":"Krishnasamy M, Hyatt A, Chung H et al (2023) Refocusing cancer supportive care: a framework for integrated cancer care. Support Care Cancer 31(1):14","journal-title":"Support Care Cancer"},{"key":"11284_CR13","unstructured":"Clinical Oncology Society of Australia Model of Survivorship Care Working Group (2016) Model of survivorship care: Critical components of cancer survivorship care in Australia Position Statement. Clinical Oncology Society of Australia."},{"issue":"6","key":"11284_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00520-025-09593-5","volume":"33","author":"C Lynex","year":"2025","unstructured":"Lynex C, Meehan D, Whittaker K et al (2025) The need for improved integration of psychosocial and supportive care in cancer: a qualitative study of Australian patient perspectives. Support Care Cancer 33(6):516","journal-title":"Support Care Cancer"},{"issue":"7","key":"11284_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00520-023-07903-3","volume":"31","author":"M Pasvanis","year":"2023","unstructured":"Pasvanis M, Hegarty S, Russell H et al (2023) Exploring the experiences and priorities of women with a diagnosis of ovarian cancer. Support Care Cancer 31(7):432","journal-title":"Support Care Cancer"},{"issue":"9","key":"11284_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM (1999) Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 89(9):1322\u20131327","journal-title":"Am J Public Health"},{"key":"11284_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/IGC.0000000000000167","volume":"24","author":"MT King","year":"2014","unstructured":"King MT, Stockler MR, Butow P et al (2014) Development of the Measure of Ovarian Symptoms and Treatment Concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer. Int J Gynecol Cancer 24:865\u2013873","journal-title":"Int J Gynecol Cancer"},{"key":"11284_CR18","doi-asserted-by":"crossref","unstructured":"King MT, Stockler MR, O\u2019Connell RL ... for the GCIG Symptom Benefit group (2018) Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer. Quality Life Research 27:59\u201374.","DOI":"10.1007\/s11136-017-1729-8"},{"key":"11284_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/S0033291796004242","volume":"27","author":"DP Goldberg","year":"1997","unstructured":"Goldberg DP, Gater R, Sartorius N et al (1997) The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27:191\u2013197","journal-title":"Psychol Med"},{"key":"11284_CR20","volume-title":"General health questionnaire (GHQ)","author":"D Goldberg","year":"2000","unstructured":"Goldberg D, Williams P (2000) General health questionnaire (GHQ). Nelson, Swindon, Wiltshire, UK"},{"issue":"3","key":"11284_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy (FACT) Scale: development and validation of the general measure. J Clin Oncol 11(3):570\u2013579","journal-title":"J Clin Oncol"},{"issue":"4","key":"11284_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2753.2008.01057.x","volume":"15","author":"A Boyes","year":"2009","unstructured":"Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients\u2019 perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract 15(4):602\u2013606","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"11284_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11764-014-0384-0","volume":"9","author":"C Foster","year":"2015","unstructured":"Foster C, Breckons M, Cotterell P et al (2015) Cancer survivors\u2019 self-efficacy to self-manage in the year following primary treatment. J Cancer Surviv 9(1):11\u201319","journal-title":"J Cancer Surviv"},{"issue":"2","key":"11284_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77\u2013101","journal-title":"Qual Res Psychol"},{"issue":"11","key":"11284_CR25","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1002\/pon.3322","volume":"22","author":"KB Roland","year":"2013","unstructured":"Roland KB, Rodriguez JL, Patterson JR, Trivers KF (2013) A literature review of the social and psychological needs of ovarian cancer survivors. Psychooncology 22(11):2408\u20132418","journal-title":"Psychooncology"},{"key":"11284_CR26","volume-title":"Optimal care pathway for women with ovarian cancer","author":"Cancer Council Victoria","year":"2021","unstructured":"Cancer Council Victoria, Department of Health Victoria (2021) Optimal care pathway for women with ovarian cancer, 2nd edn. Cancer Council Victoria, Melbourne","edition":"2nd edn"},{"issue":"1","key":"11284_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ygyno.2018.05.017","volume":"150","author":"VE von Gruenigen","year":"2018","unstructured":"von Gruenigen VE, Huang HQ, Cella D et al (2018) Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: an NRG Oncology\/Gynecologic Oncology Group study. Gynecol Oncol 150(1):119\u2013126","journal-title":"Gynecol Oncol"},{"key":"11284_CR28","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/pon.4742","volume":"27","author":"MJA Rietveld","year":"2018","unstructured":"Rietveld MJA, Husson O, Vos MC et al (2018) Association between information provision and supportive care needs among ovarian cancer survivors: a cross-sectional study from the PROFILES registry. Psychooncology 27:1922\u20131929","journal-title":"Psychooncology"},{"key":"11284_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102825","volume":"76","author":"RJ Chan","year":"2024","unstructured":"Chan RJ, Knowles R, Ashbury FD et al (2024) Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care - an international Delphi study. eClinicalMedicine 76:102825","journal-title":"eClinicalMedicine"},{"issue":"9","key":"11284_CR30","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1007\/s00520-022-07052-z","volume":"30","author":"C Kwok","year":"2022","unstructured":"Kwok C, Degen C, Moradi N, Stacey D (2022) Nurse-led telehealth interventions for symptom management in patients with cancer receiving systemic or radiation therapy: a systematic review and meta-analysis. Support Care Cancer 30(9):7119\u20137132","journal-title":"Support Care Cancer"},{"issue":"4","key":"11284_CR31","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1188\/17.ONF.E168-E184","volume":"44","author":"S-R Suh","year":"2017","unstructured":"Suh S-R, Lee MK (2017) Effects of nurse-led telephone-based supportive interventions for patients with cancer: a meta-analysis. Oncol Nurs Forum 44(4):e168\u2013e184","journal-title":"Oncol Nurs Forum"},{"key":"11284_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-024-01643-x","author":"P Pradhan","year":"2024","unstructured":"Pradhan P, Sharman AR, Palme CE et al (2024) Models of survivorship care in patients with head and neck cancer in regional, rural, and remote areas: a systematic review. J Cancer Surviv. https:\/\/doi.org\/10.1007\/s11764-024-01643-x","journal-title":"J Cancer Surviv"},{"issue":"8","key":"11284_CR33","doi-asserted-by":"publisher","first-page":"CD006119","DOI":"10.1002\/14651858.CD006119.pub4","volume":"8","author":"G Zachou","year":"2023","unstructured":"Zachou G, El-Khouly F, Dilley J (2023) Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment. Cochrane Database Syst Rev 8(8):CD006119","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"11284_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/IGC.0000000000000877","volume":"27","author":"A Lanceley","year":"2017","unstructured":"Lanceley A, Berzuini C, Burnell M et al (2017) Ovarian cancer follow-up: a preliminary comparison of 2 approaches. Int J Gynecol Cancer 27(1):59\u201368","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"11284_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ejon.2008.06.002","volume":"12","author":"A Cox","year":"2008","unstructured":"Cox A, Bull E, Cockle-Hearne J et al (2008) Nurse led telephone follow up in ovarian cancer: a psychosocial perspective. Eur J Oncol Nurs 12(5):412\u2013417","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"11284_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/ijgc-2021-002999","volume":"32","author":"PA Cohen","year":"2022","unstructured":"Cohen PA, Webb PM, King M et al (2022) Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer. Int J Gynecol Cancer 32(4):560\u2013565","journal-title":"Int J Gynecol Cancer"},{"key":"11284_CR37","unstructured":"Cancer Australia (2023). Australian Cancer Plan (Summary), Cancer Australia, Surry Hills, NSW. Available from: https:\/\/www.australiancancerplan.gov.au\/welcome. Accessed 24 Sep 2025."}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11284-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:08Z","timestamp":1792086488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11284-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11284"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11284-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Approval was granted by the Queensland University of Technology (QUT) Human Research Ethics Committee (UHREC) (Approval number: 1900001068). Written informed consent was obtained from all participants prior to their participation.","order":1,"name":"Ethics","label":"Ethics declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.H., C.D., A.T., N.W. and B.B. were employees of Ovarian Cancer Australia during the conduct of the study. All other authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1067"}}